drugset / Trial / NCT02685228
Decitabine Combined With Gemcitabine in First-line Treatment of AdvancedPancreatic Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the effect of very low dose decitabine combinate with gemcitabine in the first-line treatment of locally advanced, unresectable and metastatic pancreatic cancer.
Timeline
- Start
- 2016-03
- Primary completion
- 2017-12
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Decitabine | Small molecule | 5 mg/m2 | — |
| Subject | Gemcitabine | Small molecule | 1 g | — |